- Eledon Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Q1 2023 Eledon Pharmaceuticals Inc Earnings Call TranscriptMay 11, 2023€2.52 (-4.55%)Earnings
- Q4 2022 Eledon Pharmaceuticals Inc Earnings Call TranscriptMar 30, 2023€2.18 (+4.81%)Earnings
- Eledon Pharmaceuticals Inc at SVB Securities Global Biopharma Conference (Virtual) TranscriptFeb 15, 2023
- Q3 2022 Eledon Pharmaceuticals Inc Earnings Call TranscriptNov 14, 2022€2.58 (+8.40%)Earnings
- Eledon Pharmaceuticals Inc at Ladenburg Thalmann Healthcare Conference TranscriptSep 29, 2022
- Eledon Pharmaceuticals Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 12, 2022
- Eledon Pharmaceuticals Inc at Gilmartin Group Inaugural Emerging Growth Company Showcase (Virtual) TranscriptAug 31, 2022
- Q2 2022 Eledon Pharmaceuticals Inc Earnings Call TranscriptAug 11, 2022€3.28 (+1.86%)Earnings
- Eledon Pharmaceuticals Inc at Jefferies Healthcare Conference TranscriptJun 09, 2022
- Q1 2022 Eledon Pharmaceuticals Inc Earnings Call TranscriptMay 12, 2022€2.44 (+0.83%)Earnings
- Eledon Pharmaceuticals Inc at Noble Capital Markets Investor Conference (Virtual) TranscriptApr 21, 2022
- Q4 2021 Eledon Pharmaceuticals Inc Earnings Call TranscriptMar 24, 2022€3.38 (+3.68%)Earnings
- Q3 2021 Eledon Pharmaceuticals Inc Earnings Call TranscriptNov 11, 2021€4.22 (-1.40%)Earnings
- Q2 2021 Eledon Pharmaceuticals Inc Earnings Call TranscriptAug 12, 2021€5.5 (+2.80%)Earnings
- Q1 2021 Eledon Pharmaceuticals Inc Earnings Call TranscriptMay 13, 2021€7.6 (-2.56%)Earnings
- Eledon Pharmaceuticals Inc at NobleCon Investor Conference (Virtual) TranscriptJan 20, 2021
Q4 2022 Eledon Pharmaceuticals Inc Earnings Call Transcript
Greetings, and welcome to the Eledon Pharmaceuticals fourth quarter and full-year 2022 financial results conference call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference is being recorded today, March 30th, 2023.
At this time, I would now like to turn the conference call over to Paul Little, Chief Financial Officer of Eledon. Please go ahead, sir.
Good afternoon, everyone, and thank you for joining Eledon's fourth quarter and full-year 2022 operating and financial results conference call. And joined on today's call by David Alexandre Gros, Chief Executive Officer; and Steve Perrin, our President and Chief Scientific Officer; Jeff Bornstein, our Chief Medical Officer is not present today, as he is traveling to the World Congress of Nephrology. Earlier today, Eledon issued a press release announcing financial results for the fourth quarter and full year ended December 31st, 2022. You may access the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)